HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
Introduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354251314514 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591278613725184 |
---|---|
author | Alexandre Chan PharmD Daniella Chan BS Ding Quan Ng BSPharm Huang Fang Zheng MD Quan Ming Tan MCM Chia Jie Tan PhD Jolene Hui Min Toh BS Ning Yi Yap PhD Yi Long Toh PhD Yu Ke PhD Edmund Chun Ann Wang BS Queenie Pei Ni Lim BSocSc Han Kiat Ho PhD Lita Chew MMS Tira J. Tan MBBS |
author_facet | Alexandre Chan PharmD Daniella Chan BS Ding Quan Ng BSPharm Huang Fang Zheng MD Quan Ming Tan MCM Chia Jie Tan PhD Jolene Hui Min Toh BS Ning Yi Yap PhD Yi Long Toh PhD Yu Ke PhD Edmund Chun Ann Wang BS Queenie Pei Ni Lim BSocSc Han Kiat Ho PhD Lita Chew MMS Tira J. Tan MBBS |
author_sort | Alexandre Chan PharmD |
collection | DOAJ |
description | Introduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety of a TCM concoction, modified Xiang Bei Yang Rong Tang (XBYRT), on quality of life (QOL), cancer-related fatigue (CRF), and cognitive symptoms, compared to placebo. Methods: In a single-centered, randomized, double-blinded, placebo-controlled pilot trial conducted from 2019 to 2022, fatigued cancer survivors ≥21 years old were recruited to receive the XBYRT intervention or placebo (5% diluted) once daily for the duration of 8 weeks. Patient-reported outcomes for QOL, CRF, cognition, blood samples for biomarker testing, and adverse events were collected at baseline (T0), 4 weeks (T1), 8 weeks (T2), and 10 weeks (T3) after baseline. Linear regression was performed to evaluate differences between groups at T2 and T3. Results: A total of 1502 patients were screened, with 672 patients considered eligible. Of the eligible, 15 XBYRT and 13 placebo subjects with similar mean ages (58.5 vs 58.4) were recruited. Both groups were predominantly Chinese (93% vs 62%), breast cancer patients (87% vs 62%), and diagnosed with stage 2 cancer (60% vs 46%). Although no significant difference was found in QOL between groups, the XBYRT group exhibited improved emotional fatigue at T3 ( P = .045) and higher BDNF levels at T2 ( P = .047) and T3 ( P = .029). After baseline adjustment, XBYRT was associated with better perceived cognitive impairment at T2 ( P = .011) and T3 ( P = .017), as well as overall perceived cognitive function at T3 ( P = .028). XBYRT is well tolerated, with grade 3 adverse events reported in three XBYRT (20%) and two placebo (15%) subjects. Conclusion: In this pilot study, XBYRT as an integrative therapy is safe and generates encouraging improvements in cognitive and fatigue symptoms. Difficulties with recruitment limited the generalizability of trial findings, thus findings should be verified through a larger, multi-centered trial. |
format | Article |
id | doaj-art-0184326d92374fc8beb3994006405b5e |
institution | Kabale University |
issn | 1552-695X |
language | English |
publishDate | 2025-01-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Integrative Cancer Therapies |
spelling | doaj-art-0184326d92374fc8beb3994006405b5e2025-01-22T14:03:30ZengSAGE PublishingIntegrative Cancer Therapies1552-695X2025-01-012410.1177/15347354251314514HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ TrialAlexandre Chan PharmD0Daniella Chan BS1Ding Quan Ng BSPharm2Huang Fang Zheng MD3Quan Ming Tan MCM4Chia Jie Tan PhD5Jolene Hui Min Toh BS6Ning Yi Yap PhD7Yi Long Toh PhD8Yu Ke PhD9Edmund Chun Ann Wang BS10Queenie Pei Ni Lim BSocSc11Han Kiat Ho PhD12Lita Chew MMS13Tira J. Tan MBBS14University of California Irvine, Irvine, CA, USAUniversity of California Irvine, Irvine, CA, USAUniversity of California Irvine, Irvine, CA, USASingapore Thong Chai Medical Institution, Singapore, SingaporeSingapore Thong Chai Medical Institution, Singapore, SingaporeUniversity of Utah, Salt Lake City, UT, USANational University of Singapore, Singapore, SingaporeSubang Jaya Medical Centre, Subang Jaya, MalaysiaNational University of Singapore, Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational University of Singapore, Singapore, SingaporeNational University of Singapore, Singapore, SingaporeNational Cancer Centre Singapore, SingaporeIntroduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety of a TCM concoction, modified Xiang Bei Yang Rong Tang (XBYRT), on quality of life (QOL), cancer-related fatigue (CRF), and cognitive symptoms, compared to placebo. Methods: In a single-centered, randomized, double-blinded, placebo-controlled pilot trial conducted from 2019 to 2022, fatigued cancer survivors ≥21 years old were recruited to receive the XBYRT intervention or placebo (5% diluted) once daily for the duration of 8 weeks. Patient-reported outcomes for QOL, CRF, cognition, blood samples for biomarker testing, and adverse events were collected at baseline (T0), 4 weeks (T1), 8 weeks (T2), and 10 weeks (T3) after baseline. Linear regression was performed to evaluate differences between groups at T2 and T3. Results: A total of 1502 patients were screened, with 672 patients considered eligible. Of the eligible, 15 XBYRT and 13 placebo subjects with similar mean ages (58.5 vs 58.4) were recruited. Both groups were predominantly Chinese (93% vs 62%), breast cancer patients (87% vs 62%), and diagnosed with stage 2 cancer (60% vs 46%). Although no significant difference was found in QOL between groups, the XBYRT group exhibited improved emotional fatigue at T3 ( P = .045) and higher BDNF levels at T2 ( P = .047) and T3 ( P = .029). After baseline adjustment, XBYRT was associated with better perceived cognitive impairment at T2 ( P = .011) and T3 ( P = .017), as well as overall perceived cognitive function at T3 ( P = .028). XBYRT is well tolerated, with grade 3 adverse events reported in three XBYRT (20%) and two placebo (15%) subjects. Conclusion: In this pilot study, XBYRT as an integrative therapy is safe and generates encouraging improvements in cognitive and fatigue symptoms. Difficulties with recruitment limited the generalizability of trial findings, thus findings should be verified through a larger, multi-centered trial.https://doi.org/10.1177/15347354251314514 |
spellingShingle | Alexandre Chan PharmD Daniella Chan BS Ding Quan Ng BSPharm Huang Fang Zheng MD Quan Ming Tan MCM Chia Jie Tan PhD Jolene Hui Min Toh BS Ning Yi Yap PhD Yi Long Toh PhD Yu Ke PhD Edmund Chun Ann Wang BS Queenie Pei Ni Lim BSocSc Han Kiat Ho PhD Lita Chew MMS Tira J. Tan MBBS HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial Integrative Cancer Therapies |
title | HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial |
title_full | HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial |
title_fullStr | HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial |
title_full_unstemmed | HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial |
title_short | HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial |
title_sort | health related quality of life intervention in survivors of breast and other cancers experiencing cancer related fatigue and associated cognitive symptoms using traditional chinese medicine the herbal trial |
url | https://doi.org/10.1177/15347354251314514 |
work_keys_str_mv | AT alexandrechanpharmd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT daniellachanbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT dingquanngbspharm healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT huangfangzhengmd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT quanmingtanmcm healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT chiajietanphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT jolenehuimintohbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT ningyiyapphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT yilongtohphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT yukephd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT edmundchunannwangbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT queeniepeinilimbsocsc healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT hankiathophd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT litachewmms healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial AT tirajtanmbbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial |